.svg){kind=small}
Jan-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In Illinois, Remedi has shown notable consistency and resilience across several categories. In the Tincture & Sublingual category, the brand maintained a steady third-place ranking from November 2024 through January 2025, demonstrating its strong hold in this segment. However, in the Capsules category, Remedi experienced a slight decline, moving from fifth place in October 2024 to seventh place by December, before slightly recovering to sixth in January 2025. This fluctuation suggests a competitive landscape in the Capsules category, although it remains within the top 10. In Concentrates, Remedi saw a positive upward trend, improving from 19th place in October to 14th place by December, though it slightly dipped back to 15th in January. This indicates a growing acceptance and preference for Remedi's Concentrates among consumers in Illinois.
Meanwhile, in Massachusetts, Remedi's performance in the Concentrates category presents a mixed picture. The brand's ranking fell from 15th in October 2024 to 27th in November, suggesting a potential challenge or increased competition during that period. However, Remedi managed to climb back up to 23rd place by January 2025, indicating a partial recovery and adaptability in the Massachusetts market. The brand's ability to rebound could be attributed to strategic adjustments or changes in consumer preferences. Despite not breaking into the top 20 consistently, the upward movement towards the end of the period could hint at potential future gains if the trend continues.
Competitive Landscape
In the competitive landscape of concentrates in Illinois, Remedi has shown a dynamic performance over the past few months. Starting from October 2024, Remedi was ranked 19th, but by December 2024, it climbed to 14th, before slightly dropping to 15th in January 2025. This fluctuation in rank indicates a competitive market where brands like Avexia and nuEra have consistently maintained higher ranks, with nuEra even reaching as high as 10th in November 2024. Despite the competitive pressure, Remedi's sales saw a significant increase in December 2024, suggesting a strong market presence and consumer preference during that period. However, maintaining this momentum is crucial as competitors like Verano and Superflux are also improving their standings, indicating a need for strategic marketing and product differentiation to sustain and enhance Remedi's market position.
Notable Products
In January 2025, the top-performing product for Remedi was the Indica Rest RSO Dropper 0.5g in the Concentrates category, maintaining its rank as number one from the previous month with sales of 3226. The Indica Relief RSO Syringe 0.5g, also in Concentrates, held the second position, a slight drop from its first-place ranking in December 2024. OG Kush Breath RSO 1g emerged as a new contender, securing the third spot in its debut month. The CBD/THC 1:5 Rest Tincture 30ml maintained its fourth-place position from December 2024, showing consistent performance. Meanwhile, the Indica Rest RSO Syringe 0.5g fell from third to fifth place, reflecting a decrease in its sales momentum.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
